JX-7002

N/A

Report date: 2023/01/07 17:46:08

Base Information

Drug NameJX-7002
Drug Alias NameJX7002JX-7002
ClassificationBiologics
Mechanisms of ActionProprotein convertase subtilisin kexin type 9 modulators
TargetsProprotein convertase subtilisin kexin type 9
Therapy Area/IndicationsHypercholesterolemiaHyperlipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesZhejiang Jingxin Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesZhejiang Jingxin Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHypercholesterolemiaHyperlipidemias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A